Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Oxford Biomedica Confirms Aura Biosciences Partnership For Phase 3 Eye Cancer Drug Manufacturing

(RTTNews) - Oxford Biomedica plc (OXB.L), a gene and cell therapy company, on Tuesday confirmed its manufacturing and supply partnership with Aura Biosciences, Inc. (AURA), a biotechnology company.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Health & Medicine

World Children’s Day show to entertain young patients at Vega Baja Hospital

The interactive performance will take place in the hospital’s assembly hall at 4pm on Friday 20 November. Orihuela’s Family Department will mark World Children’s Day with a special performance for…

  • World Children's Day celebrated at Vega Baja University General Hospital on November 20th
  • "El Baúl de los Sueños" performance features music, storytelling, and audience participation
  • Aim is to provide a break from hospital setting and quality time for young patients and families

More from Tuesday 17 November →